Optimal Dual Antiplatelet Therapy Strategy in Elderly Patients with Acute Coronary Syndrome

Overview

Journal J Geriatr Cardiol

Specialty Geriatrics

Date 2021 Apr 28

PMID 33907551

Citations 1

Authors

Monica Verdoia

Rocco Gioscia

Giuseppe De Luca

Affiliations

Soon will be listed here.

Abstract

One out of three hospitalizations for acute coronary syndrome (ACS) involve nowadays elderly patients, carrying together a significant burden of comorbidities and a higher risk of complications. In particular, both ischemic and haemorrhagic risk are markedly enhanced in advanced age, and strictly interconnected, challenging the management of dual antiplatelet therapy (DAPT) in these patients. The recent development of several therapeutic options in terms of duration and combination of antiplatelet agents have offered a wider spectrum of opportunities for a more individualized approach in the management of DAPT after an ACS, although the criteria for the selection of the most appropriate strategy in each patient still lack validation. In particular, dose-adjustment, early aspirin discontinuation, laboratory-driven tailoring and shorter or extended DAPT have been addressed with promising safety and efficacy results. The present review provides an updated overview on the emerging evidencefrom randomized clinical trials and subanalyses dedicated to the management of DAPT in elderly patients presenting with ACS.

Citing Articles

Estimated Intake of Potassium, Phosphorus and Zinc with the Daily Diet Negatively Correlates with ADP-Dependent Whole Blood Platelet Aggregation in Older Subjects.

Karolczak K, Guligowska A, Soltysik B, Kostanek J, Kostka T, Watala C Nutrients. 2024; 16(3).

PMID: 38337617 PMC: 10857292. DOI: 10.3390/nu16030332.

References

Jones C . Platelet function and ageing. Mamm Genome. 2016; 27(7-8):358-66. PMC: 4935731. DOI: 10.1007/s00335-016-9629-8. View

Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S . Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016; 387(10023):1057-1065. DOI: 10.1016/S0140-6736(15)01166-6. View

Savonitto S, Ferri L, Piatti L, Grosseto D, Piovaccari G, Morici N . Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization. Circulation. 2018; 137(23):2435-2445. DOI: 10.1161/CIRCULATIONAHA.117.032180. View

Crimi G, Morici N, Ferrario M, Ferri L, Piatti L, Grosseto D . Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel. J Am Heart Assoc. 2019; 8(2):e010956. PMC: 6497351. DOI: 10.1161/JAHA.118.010956. View

Kaul P, Alexander K, Ohman E, Savu A, Roe M, Goodman S . Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial. Can J Cardiol. 2019; 35(4):430-437. DOI: 10.1016/j.cjca.2018.12.035. View

Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T . Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet. 2017; 390(10104):1747-1757. DOI: 10.1016/S0140-6736(17)32155-4. View

Verdoia M, Schaffer A, Barbieri L, Bellomo G, Marino P, Sinigaglia F . Impact of age on mean platelet volume and its relationship with coronary artery disease: a single-centre cohort study. Exp Gerontol. 2015; 62:32-6. DOI: 10.1016/j.exger.2014.12.019. View

Kupka D, Sibbing D . De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention. Korean Circ J. 2018; 48(10):863-872. PMC: 6158449. DOI: 10.4070/kcj.2018.0255. View

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp C . Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel. J Thromb Haemost. 2009; 8(1):37-42. DOI: 10.1111/j.1538-7836.2009.03644.x. View

10.

Alexopoulos D, Xanthopoulou I, Storey R, Bliden K, Tantry U, Angiolillo D . Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis. Am Heart J. 2014; 168(4):530-6. DOI: 10.1016/j.ahj.2014.06.026. View

11.

Zaman M, Stirling S, Shepstone L, Ryding A, Flather M, Bachmann M . The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP). Eur Heart J. 2014; 35(23):1551-8. DOI: 10.1093/eurheartj/ehu039. View

12.

De Luca G, Dirksen M, Spaulding C, Kelbaek H, Schalij M, Thuesen L . Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation). Am J Cardiol. 2013; 112(2):181-6. DOI: 10.1016/j.amjcard.2013.03.012. View

13.

Montalto C, Crimi G, Morici N, Piatti L, Grosseto D, Sganzerla P . Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores. Int J Cardiol. 2020; 328:22-28. DOI: 10.1016/j.ijcard.2020.11.065. View

14.

Guerrero C, Ariza-Sole A, Formiga F, Martinez-Selles M, Vidan M, Aboal J . Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction. J Geriatr Cardiol. 2019; 15(12):713-717. PMC: 6330266. DOI: 10.11909/j.issn.1671-5411.2018.12.003. View

15.

Husted S, James S, Becker R, Horrow J, Katus H, Storey R . Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes. 2012; 5(5):680-8. DOI: 10.1161/CIRCOUTCOMES.111.964395. View

16.

Mehran R, Baber U, Sharma S, Cohen D, Angiolillo D, Briguori C . Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med. 2019; 381(21):2032-2042. DOI: 10.1056/NEJMoa1908419. View

17.

De Luca G, Vant Hof A, Huber K, Gibson C, Bellandi F, Arntz H . Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. Heart Vessels. 2013; 29(1):15-20. DOI: 10.1007/s00380-013-0323-4. View

18.

Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrie D . Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2017; 391(10115):41-50. DOI: 10.1016/S0140-6736(17)32713-7. View

19.

Verdoia M, Kedhi E, Suryapranata H, Frati G, Biondi-Zoccai G, De Luca G . Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials. J Thromb Thrombolysis. 2020; 50(2):337-354. DOI: 10.1007/s11239-019-02033-2. View

20.

De Luca G, van t Hof A, Ottervanger J, Hoorntje J, Gosselink A, Dambrink J . Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur Heart J. 2005; 26(7):662-6. DOI: 10.1093/eurheartj/ehi110. View